Investing Profile

Laia Crespo

InvestorVC
Head of Investments at Sanofi Ventures
Photo of Laia Crespo, Investor at Sanofi Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$5.0M - $10.0M
$7.5M
9
CompanyStageDateRound SizeTotal Raised
Eligo Bioscience
Series BDec 2023$30M
$48M
Co-investors: Samir Kaul (Khosla Ventures)
QurAlis
Series BMar 2023$88M
$140M
Co-investors: Amy Schulman (Polaris Partners), Stephen Thompson (Brandon Capital Partners), Jeffrey Moore (MP Healthcare Venture Management), Johannes Fruehauf (Mission BioCapital), Philip Scheltens (EQT Life Sciences), Cillian King (EQT Life Sciences), Roel Bulthuis (INKEF Capital)
OMass Therapeutics
Series BApr 2022$95M
$95M
Co-investors: Scott Biller (GV (Google Ventures)), Diana Bernstein (Northpond Ventures)
Lava Therapeutics
Series CSep 2020$83M
$100M
Co-investors: Guido Magni (Versant Ventures), Nanna Luneborg (Forbion), Joël Jean-Mairet (Ysios Capital)
Inbiomotion
Series BMar 2016$2M
Series AJun 2012$2M
$4M
Co-investors: Jose Mesa (Alta Life Sciences), Joël Jean-Mairet (Ysios Capital)
Minoryx Therapeutics
Series AOct 2015$22M
$81M
Co-investors: Pablo Cironi (Caixa Capital), Carlos Esteban (Faber), Thierry Laugel (Kurma Partners), Monique Schiersing (Roche Venture Fund)
AM Pharma
Series ESep 2014$16M
Series DSep 2011$40M
$210M
Co-investors: Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion), Rémi Droller (Kurma Partners)